High-content analysis of three-dimensional tumor spheroids: investigating signaling pathways using small hairpin RNA
Introduction
In cancer drug discovery, gene knockdown by RNA interference (RNAi) has demonstrated tremendous success as a research tool for the rapid identification of novel genes and signaling pathway candidates that could make ideal targets. Traditionally, in vitro studies utilizing RNAi have been conducted in cells grown on two-dimensional (2D) surfaces. Such studies fail to take into account the cell-to-cell and cell-to-extracellular matrix interactions that occur in patient tumor biology.
Conducting RNAi screens in 3D, particularly when targeting genes that affect these interactions, may reveal more biologically relevant signaling pathways that occur between complex layers of cells and their surrounding matrix proteins. 3D cell spheroids, which are microscale 3D aggregates of cells, possess characteristics that make them ideal for anticancer drug screening: they are simple to form, have cell-to-cell and cell-to-matrix interactions that more accurately mimic in vivo physiology, and can be utilized with high-content imaging devices for HTS.
Here, we describe the use of 3D spheroids formed in Perfecta3D ® Hanging Drop Plates (HDPs) as an HTS colorectal cancer model to test the effects of genetic loss of function on spheroid formation and maintenance. Spheroid formation was analyzed with the acumen ® e X3 high-content imaging system.
High-content analysis of 3D spheroid cultures
An HTS 3D spheroid model of colorectal cancer tumor formation was developed to test whether the silencing of specific integrin receptor and receptor tyrosine kinase (RTK) genes inhibited spheroid formation.
3D spheroid cultures were generated in the Perfecta3D ® HDPs from 3D Biomatrix. Perfecta3D ® HDPs are perfectly suited for the experiments described here because they enable easy spheroid formation and are available in a 384-well HTS format (Fig. 1) . After formation, spheroids were transferred to assay plates for imaging with the high-content screening instrument acumen ® e X3 from TTP LabTech.
The acumen ® e X3 screening instrument ( Fig. 2) performs multicolor, whole-well imaging and is unique in that its wide depth of field is sufficient to capture spheroids without requiring Z-stack assembly. The acumen ® e X3 allowed for rapid quantification of spheroid formation. 
High-content analysis of the 3D spheroid model postinfection
For analysis of viability and spheroid formation after viral infection, the shRNA-EGFP-lentivirus spheroids were transferred into 384-well, black-sided, clear-bottom imaging plates (Greiner) and imaged via the acumen ® e X3 high-content imager (Fig. 3a) . The nontargeting shRNA-EGFP-lentivirus and the ensuing viral infection did not noticeably alter spheroid formation, indicating that this is an efficient system to deliver shRNAs to spheroids.
Effects of RTK and integrin gene suppression on spheroid formation
The puro-selection method was utilized to infect cells with shRNA-expressing lentiviruses against platelet-derived growth factor receptor-α (PDGDFRα), PDGDFRβ, integrin β1 (ITGβ1) or a nontargeting shRNA-puro-lentivirus control (NT control).
After 3 d, spheroids were transferred into 384-well assay plates as described above, stained with calcein AM and imaged on the acumen ® e X3. Relative spheroid formation was calculated by dividing the average total intensity measurement of the shRNA-infected spheroids by the average total intensity measurement of the NT control spheroids. As shown in Figure 3b , genetic knockdown of PDGDFRα, PDGDFRβ or ITGβ1 led to significantly less spheroid formation than that seen with the NT control.
Conclusion
Combining RNAi technology with 3D spheroid models and acumen ® high-content imaging revealed that lowering PDGDFRα, PDGFRβ or Growing cells in 3D yields gene expression patterns more similar to those seen in vivo; therefore, interrogating gene function in 3D rather than 2D may significantly accelerate chemotherapeutic drug discovery. This 3D platform may represent a new screening paradigm from which targets related specifically to 3D tumor structural growth can be revealed and exploited for therapeutic intervention.
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